Development of novel animal model for heart failure with a preserved ejection fraction Read more about Development of novel animal model for heart failure with a preserved ejection fraction
Cardiac fibroblast as target for novel therapy in heart failure with a preserved ejection fraction Read more about Cardiac fibroblast as target for novel therapy in heart failure with a preserved ejection fraction
Novel, targeted therapy for heart failure with a preserved ejection fraction Read more about Novel, targeted therapy for heart failure with a preserved ejection fraction
Investigation of pulmonary vascular function in the setting of heart failure with preserved ejection fraction Read more about Investigation of pulmonary vascular function in the setting of heart failure with preserved ejection fraction
Atypical diabetes mellitus associated with Kabuki syndrome. Read more about Atypical diabetes mellitus associated with Kabuki syndrome.
Influence of epigenetic modifications in the clinical remission phase (honeymoon period) of adult-onset Type 1 Diabetes Read more about Influence of epigenetic modifications in the clinical remission phase (honeymoon period) of adult-onset Type 1 Diabetes
Anti-fibrotic and/or anti-inflammatory compound/s for the treatment of heart failure Read more about Anti-fibrotic and/or anti-inflammatory compound/s for the treatment of heart failure
International Consortium Study Investigating DNA Methylation and Risk of Diabetic Complications Read more about International Consortium Study Investigating DNA Methylation and Risk of Diabetic Complications
Set7 methyltransferase as a target to reduce the burden of diabetic complications Read more about Set7 methyltransferase as a target to reduce the burden of diabetic complications
